Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy

INTRODUCTION: In early-stage HER2 positive breast cancer (BC) patients, tumor response to neoadjuvant chemotherapy (NACT) predict survival outcomes. Patients achieving less than pathological complete response (pCR) have a worse prognosis, however, this group is heterogeneous. Nowadays limited data o...

Descripción completa

Detalles Bibliográficos
Autores principales: Omarini, Claudia, Bettelli, Stefania, Manfredini, Samantha, Barbolini, Monica, Isca, Chrystel, Cortesi, Giulia, Maiorana, Antonino, Tazzioli, Giovanni, Dominici, Massimo, Piacentini, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264751/
https://www.ncbi.nlm.nih.gov/pubmed/32485588
http://dx.doi.org/10.1016/j.tranon.2020.100794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264751/
https://www.ncbi.nlm.nih.gov/pubmed/32485588
http://dx.doi.org/10.1016/j.tranon.2020.100794

Ejemplares similares